Adora Animal Health Secures First U.S. Patent, Advancing Development of Generic PSGAG for Veterinary Use

Franklin-based Adora Animal Health Corporation (Adora) has announced the publication of its first U.S. patent, US Patent 12,059,430. This significant milestone relates to innovative processes developed by Adora to produce a purified form of the active ingredient in its injectable veterinary generic PSGAG (Polysulfated Glycosaminoglycan), which is widely recognized under the brand name Adequan, marketed by American Regent.